Skip to main content

Lenalidomide Capsules Shortage

Last Updated: January 15, 2025
Status: Current

Products Affected - Description
    • Lenalidomide oral capsule, Alvogen, 10 mg, bottle, 100 count, NDC 47811-0485-01
    • Lenalidomide oral capsule, Alvogen, 15 mg, bottle, 100 count, NDC 47811-0486-01
    • Lenalidomide oral capsule, Alvogen, 20 mg, bottle, 21 count, NDC 47811-0487-77
    • Lenalidomide oral capsule, Alvogen, 25 mg, bottle, 100 count, NDC 47811-0488-01
    • Lenalidomide oral capsule, Alvogen, 5 mg, bottle, 100 count, NDC 47811-0484-01
    • Lenalidomide oral capsule, Apotex, 10 mg, bottle, 28 count, NDC 60505-4534-02
    • Lenalidomide oral capsule, Apotex, 15 mg, bottle, 21 count, NDC 60505-4535-02
    • Lenalidomide oral capsule, Apotex, 2.5 mg, bottle, 28 count, NDC 60505-4532-02
    • Lenalidomide oral capsule, Apotex, 20 mg, bottle, 21 count, NDC 60505-4536-02
    • Lenalidomide oral capsule, Apotex, 25 mg, bottle, 21 count, NDC 60505-4537-02
    • Lenalidomide oral capsule, Apotex, 5 mg, bottle, 28 count, NDC 60505-4533-02
    • Lenalidomide oral capsule, Camber, 10 mg, bottle, 28 count, NDC 31722-0259-28
    • Lenalidomide oral capsule, Camber, 15 mg, bottle, 21 count, NDC 31722-0260-21
    • Lenalidomide oral capsule, Camber, 2.5 mg, bottle, 28 count, NDC 31722-0257-28
    • Lenalidomide oral capsule, Camber, 20 mg, bottle, 21 count, NDC 31722-0261-21
    • Lenalidomide oral capsule, Camber, 25 mg, bottle, 21 count, NDC 31722-0262-21
    • Lenalidomide oral capsule, Camber, 5 mg, bottle, 28 count, NDC 31722-0258-28
    • Lenalidomide oral capsule, Cipla USA, 2.5 mg, bottle, 28 count, NDC 69097-0604-73
    • Lenalidomide oral capsule, Sun Pharma, 10 mg, bottle, 28 count, NDC 63304-0043-27
    • Lenalidomide oral capsule, Sun Pharma, 15 mg, bottle, 21 count, NDC 63304-0044-22
    • Lenalidomide oral capsule, Sun Pharma, 2.5 mg, bottle, 28 count, NDC 63304-0041-27
    • Lenalidomide oral capsule, Sun Pharma, 20 mg, bottle, 21 count, NDC 63304-0045-22
    • Lenalidomide oral capsule, Sun Pharma, 25 mg, bottle, 21 count, NDC 63304-0046-22
    • Lenalidomide oral capsule, Sun Pharma, 5 mg, bottle, 28 count, NDC 63304-0042-27
    • Lenalidomide oral capsule, Teva, 10 mg, bottle, 28 count, NDC 00480-1243-28
    • Lenalidomide oral capsule, Teva, 15 mg, bottle, 21 count, NDC 00480-1244-21
    • Lenalidomide oral capsule, Teva, 2.5 mg, bottle, 28 count, NDC 00480-1241-28
    • Lenalidomide oral capsule, Teva, 20 mg, bottle, 21 count, NDC 00480-1245-21
    • Lenalidomide oral capsule, Teva, 25 mg, bottle, 21 count, NDC 00480-1246-21
    • Lenalidomide oral capsule, Teva, 5 mg, bottle, 28 count, NDC 00480-1242-28
Reason for the Shortage
    • Generic lenalidomide capsules have volume restrictions as part of the patent settlements between generic companies and Celgene (Bristol Myers Squibb). The volume restrictions are expected to be in effect until January 31, 2026.
    • Alvogen did not provide a reason for the shortage.
    • Apotex did not provide a reason for the shortage.
    • Bristol Myers Squibb has Revlimid available.
    • Camber allocates specific amounts to REMS certified specialty pharmacies due to the volume restrictions for lenalidomide.
    • Cipla did not provide a reason for the shortage.
    • Dr. Reddy's was not available to provide information.
    • Mylan has lenalidomide capsules available.
    • Sun Pharma did not provide a reason for the shortage.
    • Teva has lenalidomide capsules on allocation due to volume restrictions.
Available Products
    • Revlimid oral capsule, Bristol-Myers Squibb, 10 mg, bottle, 28 count, NDC 59572-0410-28
    • Revlimid oral capsule, Bristol-Myers Squibb, 10 mg, bottle, 100 count, NDC 59572-0410-00
    • Revlimid oral capsule, Bristol-Myers Squibb, 15 mg, bottle, 21 count, NDC 59572-0415-21
    • Revlimid oral capsule, Bristol-Myers Squibb, 15 mg, bottle, 100 count, NDC 59572-0415-00
    • Revlimid oral capsule, Bristol-Myers Squibb, 2.5 mg, bottle, 28 count, NDC 59572-0402-28
    • Revlimid oral capsule, Bristol-Myers Squibb, 2.5 mg, bottle, 100 count, NDC 59572-0402-00
    • Revlimid oral capsule, Bristol-Myers Squibb, 20 mg, bottle, 21 count, NDC 59572-0420-21
    • Revlimid oral capsule, Bristol-Myers Squibb, 20 mg, bottle, 100 count, NDC 59572-0420-00
    • Revlimid oral capsule, Bristol-Myers Squibb, 25 mg, bottle, 21 count, NDC 59572-0425-21
    • Revlimid oral capsule, Bristol-Myers Squibb, 25 mg, bottle, 100 count, NDC 59572-0425-00
    • Revlimid oral capsule, Bristol-Myers Squibb, 5 mg, bottle, 28 count, NDC 59572-0405-28
    • Revlimid oral capsule, Bristol-Myers Squibb, 5 mg, bottle, 100 count, NDC 59572-0405-00
    • Lenalidomide oral capsule, Alvogen, 10 mg, bottle, 28 count, NDC 47811-0485-28
    • Lenalidomide oral capsule, Alvogen, 15 mg, bottle, 21 count, NDC 47811-0486-77
    • Lenalidomide oral capsule, Alvogen, 2.5 mg, bottle, 28 count, NDC 47811-0483-28
    • Lenalidomide oral capsule, Alvogen, 25 mg, bottle, 21 count, NDC 47811-0488-77
    • Lenalidomide oral capsule, Alvogen, 5 mg, bottle, 28 count, NDC 47811-0484-28
    • Lenalidomide oral capsule, Cipla USA, 10 mg, bottle, 28 count, NDC 69097-0382-73
    • Lenalidomide oral capsule, Cipla USA, 15 mg, bottle, 21 count, NDC 69097-0383-81
    • Lenalidomide oral capsule, Cipla USA, 20 mg, bottle, 21 count, NDC 69097-0384-81
    • Lenalidomide oral capsule, Cipla USA, 25 mg, bottle, 21 count, NDC 69097-0385-81
    • Lenalidomide oral capsule, Cipla USA, 5 mg, bottle, 28 count, NDC 69097-0381-73
    • Lenalidomide oral capsule, Mylan (Viatris), 10 mg, bottle, 28 count, NDC 00378-1937-28
    • Lenalidomide oral capsule, Mylan (Viatris), 10 mg, bottle, 100 count, NDC 00378-1937-01
    • Lenalidomide oral capsule, Mylan (Viatris), 15 mg, bottle, 21 count, NDC 00378-1941-21
    • Lenalidomide oral capsule, Mylan (Viatris), 15 mg, bottle, 100 count, NDC 00378-1941-01
    • Lenalidomide oral capsule, Mylan (Viatris), 2.5 mg, bottle, 28 count, NDC 00378-1935-28
    • Lenalidomide oral capsule, Mylan (Viatris), 2.5 mg, bottle, 100 count, NDC 00378-1935-01
    • Lenalidomide oral capsule, Mylan (Viatris), 20 mg, bottle, 21 count, NDC 00378-1942-21
    • Lenalidomide oral capsule, Mylan (Viatris), 20 mg, bottle, 100 count, NDC 00378-1942-01
    • Lenalidomide oral capsule, Mylan (Viatris), 25 mg, bottle, 21 count, NDC 00378-1940-21
    • Lenalidomide oral capsule, Mylan (Viatris), 25 mg, bottle, 100 count, NDC 00378-1940-01
    • Lenalidomide oral capsule, Mylan (Viatris), 5 mg, bottle, 28 count, NDC 00378-1936-28
    • Lenalidomide oral capsule, Mylan (Viatris), 5 mg, bottle, 100 count, NDC 00378-1936-01

Estimated Resupply Dates

    • Alvogen has 20 mg capsules in 21 count bottles and all 100 count bottles on back order and the company cannot estimate a release date.
    • Apotex has lenalidomide capsules on back order and the company cannot estimate a release date.
    • Camber allocates specific amounts to REMS certified specialty pharmacies due to the volume restrictions for lenalidomide.
    • Cipla has lenalidomide 2.5 mg capsules available with short expiration dating.
    • Sun Pharma has lenalidomide capsules on back order and the company cannot estimate a release date.
    • Teva has lenalidomide capsules on allocation and estimates product will be allocated in early-March 2025 due to volume restrictions.

Updated

Updated January 15, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 11, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer